NEW YORK (GenomeWeb News) - Illumina today said it will develop custom SNP content for a multi-sample Sentrix BeadChip for Johnson & Johnson Pharmaceutical Research & Development.
 
The BeadChip platform enables researchers to analyze 12 samples and as many as 60,000 SNPs per sample on a single BeadChip. Illumina expects to use its Infinium assay to genotype "thousands" of samples provided by J&JPRD.
 
Financial details were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.